ImmunityBio, Inc. IBRX Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNoncurrent.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s inventories?
- ImmunityBio, Inc. (IBRX) reported inventories of $18.86M in Q1 2026.
- How has ImmunityBio, Inc.'s inventories changed year-over-year?
- ImmunityBio, Inc.'s inventories increased by 123.3% year-over-year, from $8.44M to $18.86M.
- What does inventories mean?
- The value of raw materials and products the company has on hand for use or sale.
- How do you interpret inventories?
- An increase may signal preparation for commercial launch or clinical trial expansion, while a decrease could indicate efficient inventory management or supply chain constraints.
- How does inventories compare across companies?
- Inventory levels are typically low for pre-commercial biotech firms and rise significantly upon product launch.